MedPath

Performance Evaluation Study for a New Meconium Detection Test

Conditions
Pregnancy
Registration Number
NCT01735695
Lead Sponsor
Laniado Hospital
Brief Summary

The purpose of this study is to collect amniotic fluid samples from pregnant women. Amniotic fluid samples will be tested for meconium with a new assay. The results will be correlated with other laboratory tests.

Detailed Description

Female volunteers will be recruited locally in a single medical center. After the occurrence of amniotic membranes rupture, amniotic fluid samples will be collected extracorporeally.

Meconium concentration levels will be measured by the new test. Other laboratory tests will be employed in order to determine the accuracy of the new test.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Provide written or oral informed consent to participate in the study and agree to comply with study procedures.
  • Pregnant.
  • Intend to seek medical care during pregnancy.
Exclusion Criteria
  • Amniotic fluid samples are mixed with urine.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Meconium concentration in amniotic fluidOne year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Laniado Hospital

🇮🇱

Natania, Israel

© Copyright 2025. All Rights Reserved by MedPath